Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience

J Ramachandran; B Kaambwa; K Muller; J Haridy; E Tse; E Tilley; V Waddell; David Gordon; D Shaw; D Huynh; J Stewart; R Nelson; M Warner; M Boyd; M A Chinnaratha; D Harding; L Ralton; A Colman; R Woodman; A J Wigg

doi:10.1111/jgh.14393

Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience

J Ramachandran, B Kaambwa, K Muller, J Haridy, E Tse, E Tilley, V Waddell, David Gordon, D Shaw, D Huynh, J Stewart, R Nelson, M Warner, M Boyd, M A Chinnaratha, D Harding, L Ralton, A Colman, R Woodman, A J Wigg

College of Medicine and Public Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Background: With its unrestricted access to direct-acting antiviral (DAA) drugs, Australia is committed to eradicating hepatitis C virus (HCV). Innovations in models of care (MOCs) and decentralization of HCV care to avoid bottlenecks associated with specialist tertiary care models are two of the strategies being employed to augment treatment capacity.

Original language	English
Pages (from-to)	68
Number of pages	1
Journal	Journal of Gastroenterology and Hepatology
Volume	33
Issue number	S2
DOIs	https://doi.org/10.1111/jgh.14393
Publication status	Published - Sept 2018
Event	Australian Gastroenterology Week 2018: Gut Matters - Brisbane Convention and Exhibition Centre, Brisbane, Australia Duration: 8 Sept 2018 → 10 Sept 2018

Keywords

Models of care
Hepatitis C
South Australia
Direct acting antiviral drugs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jgh.14393Licence: In Copyright

Cite this

Ramachandran, J., Kaambwa, B., Muller, K., Haridy, J., Tse, E., Tilley, E., Waddell, V., Gordon, D., Shaw, D., Huynh, D., Stewart, J., Nelson, R., Warner, M., Boyd, M., Chinnaratha, M. A., Harding, D., Ralton, L., Colman, A., Woodman, R., & Wigg, A. J. (2018). Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience. Journal of Gastroenterology and Hepatology, 33(S2), 68. https://doi.org/10.1111/jgh.14393

@article{2056d5a9d8ee4d9eae13f6ba4e334fc8,

title = "Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience",

abstract = "Background: With its unrestricted access to direct-acting antiviral (DAA) drugs, Australia is committed to eradicating hepatitis C virus (HCV). Innovations in models of care (MOCs) and decentralization of HCV care to avoid bottlenecks associated with specialist tertiary care models are two of the strategies being employed to augment treatment capacity.",

keywords = "Models of care, Hepatitis C, South Australia, Direct acting antiviral drugs",

author = "J Ramachandran and B Kaambwa and K Muller and J Haridy and E Tse and E Tilley and V Waddell and David Gordon and D Shaw and D Huynh and J Stewart and R Nelson and M Warner and M Boyd and Chinnaratha, {M A} and D Harding and L Ralton and A Colman and R Woodman and Wigg, {A J}",

year = "2018",

month = sep,

doi = "10.1111/jgh.14393",

language = "English",

volume = "33",

pages = "68",

journal = "Journal of Gastroenterology and Hepatology",

issn = "0815-9319",

publisher = "John Wiley & Sons, Inc",

number = "S2",

note = "Australian Gastroenterology Week 2018 : Gut Matters, GESA AGW 2018 ; Conference date: 08-09-2018 Through 10-09-2018",

}

Ramachandran, J , Kaambwa, B, Muller, K, Haridy, J, Tse, E, Tilley, E, Waddell, V, Gordon, D, Shaw, D, Huynh, D, Stewart, J, Nelson, R, Warner, M, Boyd, M, Chinnaratha, MA, Harding, D, Ralton, L, Colman, A, Woodman, R & Wigg, AJ 2018, 'Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience', Journal of Gastroenterology and Hepatology, vol. 33, no. S2, pp. 68. https://doi.org/10.1111/jgh.14393

TY - JOUR

T1 - Models of care and their cost-effectiveness in hepatitis C treatment

T2 - Australian Gastroenterology Week 2018

AU - Ramachandran, J

AU - Kaambwa, B

AU - Muller, K

AU - Haridy, J

AU - Tse, E

AU - Tilley, E

AU - Waddell, V

AU - Gordon, David

AU - Shaw, D

AU - Huynh, D

AU - Stewart, J

AU - Nelson, R

AU - Warner, M

AU - Boyd, M

AU - Chinnaratha, M A

AU - Harding, D

AU - Ralton, L

AU - Colman, A

AU - Woodman, R

AU - Wigg, A J

PY - 2018/9

Y1 - 2018/9

N2 - Background: With its unrestricted access to direct-acting antiviral (DAA) drugs, Australia is committed to eradicating hepatitis C virus (HCV). Innovations in models of care (MOCs) and decentralization of HCV care to avoid bottlenecks associated with specialist tertiary care models are two of the strategies being employed to augment treatment capacity.

AB - Background: With its unrestricted access to direct-acting antiviral (DAA) drugs, Australia is committed to eradicating hepatitis C virus (HCV). Innovations in models of care (MOCs) and decentralization of HCV care to avoid bottlenecks associated with specialist tertiary care models are two of the strategies being employed to augment treatment capacity.

KW - Models of care

KW - Hepatitis C

KW - South Australia

KW - Direct acting antiviral drugs

U2 - 10.1111/jgh.14393

DO - 10.1111/jgh.14393

M3 - Meeting Abstract

SN - 0815-9319

VL - 33

SP - 68

JO - Journal of Gastroenterology and Hepatology

JF - Journal of Gastroenterology and Hepatology

IS - S2

Y2 - 8 September 2018 through 10 September 2018

ER -

Models of care and their cost-effectiveness in hepatitis C treatment: The South Australian state-wide experience

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this